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Abstract
Genome scale data on biological systems has increasingly become available by sequencing of DNA and RNA, and
by mass spectrometric quantification of proteins and metabolites. The cellular components from which these
-omics regimes are derived act as one integrated system in vivo; thus, there is a natural instinct to integrate -omics
data types. Statistical analyses, the use of previous knowledge in the form of networks, and the use of time-resolved
measurements are three key design elements for life scientists to consider in planning integrated -omics studies.
These design elements are reviewed in the context of multiple recent systems biology studies that leverage data
from different types of -omics analyses. While most of these studies rely on well-established model organisms, the
concepts for integrating -omics data that were developed in these studies can help to enable systems research in
the field of cancer biology.
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Background
Our ability to acquire highly multivariate datasets
(“omics” datasets) on biological systems has increased
tremendously in recent years. Advances in high-
throughput DNA sequencing, RNASeq methods, and
various advances in mass spectrometry, all coordinated
with computational and algorithmic advances, have pro-
gressively lowered the barrier to accessing -omics data.
This situation is a tremendous advance and often leads
directly to a challenging question: how can I integrate
these -omics to construct a systems-level understanding?
The instinct to integrate -omics datasets with each other
is natural for systems biologists: various “-omics” regimes
of course derive from an integrated whole in whatever bio-
logical system they originate. Modern molecular research
has revealed that important insight can be found not only
within those regimes (at the genomic, epigenomic, tran-
scriptional, protein, post-translational modification, and
metabolic levels) but also through understanding interac-
tions between these regimes [1]. In this short review, we
first summarize a number of recent multi-omics studies in
cancer and then proceed to focus on a set of representative
integrated -omics case studies outside of cancer biology.
These non-cancer studies provide a general framework
from which to consider the design of integrated -omics
studies, without the constraint of viewing the problem as a
cancer-specific challenge. We feel this approach will lead to
better designs in cancer-specific studies and is justified by
the longer history of integrated studies in areas outside of
cancer research. We attempt to focus on reported studies
that employ accessible algorithms and to provide a general
approach to integrated -omics studies that will benefit both
biologists and informaticians. Where possible, we
categorize studies as either network creation studies seeking
to inform a new network (often between -omics levels), or
network function studies, seeking to understand existing
networks more fully and accurately (often within -omics
levels). The paragraphs that follow organize around three
fundamental design challenges for biologists who run
-omics integration experiments: first, the need to under-
stand the statistical behavior of each -omics independently
prior to integration; second, the need to account for rela-
tionships between the specific layers of biology that are be-
ing compared in the integrated study; and finally, the
explicit challenge to be aware of timing differences within
and between the -omics domains.* Correspondence: edward.driggers@generalmetabolics.com
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Multi-omics studies in cancer
Multiple cancer-related studies have been published in
recent years that use more than one type of -omics data
set, including metabolomics data. Multi-omics cancer
data sets are frequently “co-analyzed”—each -omics ana-
lyzed independently using statistics and then compared
graphically or qualitatively—rather than “integrated,” by
which we mean to indicate that the multiple -omics have
been merged into a single mathematical, statistical rep-
resentation of biological behavior; both approaches have
strengths and limitations. For example, one popular ap-
proach to co-analyzing -omics datasets is enrichment
analysis [2–6]. This technique evaluates the statistical
overrepresentation of a priori-assigned gene ontology
(GO) terms among a group of metabolites, genes, or en-
zymes that are found to be different between conditions
or between cancer tissue and neighboring healthy tissue.
Because the same GO terms have been used for metabo-
lites, genes, and proteins, they can be used to establish
links across -omics data sets. However, the power of this
approach is limited by the uncertainty and incomplete-
ness of the a priori GO term association, which varies
between -omics types. Because GO terms are built on
existing network information, studies whose primary
analyses are through GO list membership comparisons
are generally network function studies that enrich our
knowledge of existing networks more fully.
A second frequently used approach to co-analyzing
multi-omics data has been to plot the independently
generated results onto a known (metabolic) network [3–
5, 7, 8], which is also a network function study approach.
While these visualizations can be very helpful to develop
and communicate ideas, they are typically drawn manu-
ally and are inherently prone to interpretation, as any
(network-based) visualization is a trade-off between clar-
ity, completeness, and the use of established patterns
(for example, the convention of drawing TCA cycle
below glycolysis). There is no one-size-fits-all solution to
this challenge, and the optimum of this trade-off is influ-
enced by the author’s interpretation of the data. Conse-
quently, visualization cannot replace unbiased, statistical
data analyses but should rather be seen as a useful way
for communicating ideas.
A range of software tools are available for the
network-based visualization of -omics data, many of
which can also handle multiple types of -omics data.
Commercial products include Ingenuity Pathway Ana-
lysis [9], which can link customer data to build-in ca-
nonical pathways, and Omix [10], which is particularly
strong for metabolic networks and comes with some
modeling capabilities. Powerful open-source solutions
include Vanted [11], which can very nicely display mul-
tiple datasets simultaneous on the same map, and MetS-
cape [12], which builds onto the popular Cytoscape
software suite. Inherently platform independent are on-
line tools like Prometra [13] and Paintomics [14].
An example where the systematic and unbiased statis-
tical integration of -omics data sets has been achieved
by the correlation of metabolites and genes across a set
of biopsy samples from pancreatic tumors and neighbor-
ing healthy tissue, reported by Zhang et al. [6]. This
study utilized a weighted co-expression network analysis
routine to identify clusters of metabolites that responded
similarly across the patient cohort. Working from these
lists of coordinately produced metabolites, the authors
utilized a pathway enrichment analysis (using IPA soft-
ware) to assign the metabolites to known GO terms, en-
abling direct comparison with transcripts sharing GO
membership. The authors identified eight metabolites
and four enzymes from lipid metabolism as potential
therapeutic targets. While these were not the only hits
from the statistical data analysis, the known involvement
in the same part of metabolism presumably led the au-
thors to focus on these targets. Note that the initial use
of WGCNA, followed only afterward by GO mappings,
makes this a network creation study, which has the po-
tential to discover new pathway relationships.
In a separate study also using metabolomics and tran-
scriptomics from patient samples, data were first ana-
lyzed separately and later liked through shared
annotations [15], however, here with the goal of identi-
fying predictive biomarkers for breast cancer. As the
same pathways were independently identified in the re-
spective -omics, the combination of both analyses mu-
tually supported each other.
In some contexts, the known network relationships
within one biological regime, or even between regimes,
can help with phenotype classification. For example, an
improved classification of breast cancer tissue was
achieved by combining transcriptomics and metabolo-
mics data [16]. The authors used the Spearman correl-
ation between transcripts and each of eight metabolite
fold-changes in 34 breast tumors to identify functionally
related entities. Thus, the combined dataset is not only
larger than either single -omics data set, enabling a more
finely grained resolution for classification, but it inher-
ently contains independently collected information con-
necting the two levels, revealing information beyond
that suggested purely by a comparably larger single
-omics dataset.
The following studies differ from those mentioned
above in focusing on biological areas outside of cancer,
and for that reason, we have organized them according
to broad experimental design challenges, rather than ac-
cording to biological findings at the systems level. The
biological findings are mentioned mostly as examples for
what kind of insight can be obtained by various ap-
proaches to -omics data integration. Nevertheless, the
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design challenges highlighted here apply equally to all
systems-level multi-omics studies.
Design challenge 1: understand the statistical
behavior of the readouts from each -omics regime
independently and in detail
Many -omics studies begin with the aim of comparing
two biological states: treated vs. untreated, transformed
vs. untransformed, fed vs. starved, etc. A strictly two-
state comparison, where one state serves as the baseline
control for measurements in the other state, provides a
terrific basis for network function studies that bring
greater insight and confidence to existing networks but
is highly limited in guiding the creation of previously
unknown networks. Counterintuitively, collecting -omics
data from multiple -omics types within a biological sys-
tem does not guarantee that it will be possible to learn
about the relationship between those -omics types; the
fundamental reason for this limitation is explained in
Fig. 1a–c. In contrast, when multiple perturbations are
applied, creating multiple biological states for -omics
comparison (one such example is time-course informa-
tion; see discussion below), the resulting integrated data
can be used in a network creation study to inform the
creation of new networks that capture relationships be-
tween -omics regimes within the system, as depicted in
Fig. 1c. However, for both categories—two-state and
multi-state—a key design challenge is to understand the
specific dynamic range, signal-to-noise, confidence inter-
vals, and associated p values within the specific individ-
ual -omics datasets that comprise the study. Values that
are sometimes imported wholesale from the heuristics of
the field at large (e.g., “take signals that are >2-fold up
or down”) risk seriously compromising integrated -omics
research, as these statistics will guide the choice of inte-
gration method and the approach to interpretation of
the findings.
Attempting to understand the simultaneous transcrip-
tional and metabolic factors that participate in macro-
phage polarization, Jha et al. [17] compared the
simultaneous transcriptional and metabolomics profiles
in each of two different activated forms of mouse macro-
phage, M1 and M2, to the same unactivated M0 baseline
control—in each case, a strict two-state comparison. A
number of transcriptional profiling studies had been
reported for this experimental system previously, provid-
ing a set of expected responses within the transcripto-
mics; additionally, accepted metabolite markers of
polarization such as itaconic acid had been reported,
along with the known networks of mammalian metabol-
ism, and so, -omics integration was employed to provide
added confidence and insight into differences in the
metabo-transcriptional network between the two differ-
ent states (i.e., a network function study). In order to en-
able the integration, using a variation of the BioNet
algorithm on a global murine cellular reaction network,
multiple hypothesis-corrected p values for each metabol-
ite and transcript were utilized as inputs for the method
(rather than bulk cut-off values). Among the novel find-
ings of this integrated study was a metabolic break-point
in the TCA-cycle of M1 macrophages at the isocitrate
dehydrogenase (IDH) step, which was subsequently vali-
dated using 13C tracer studies. However, note that the
researchers did not report any previously undiscovered
network connections within or between transcription
and metabolism, due to the inherent limitation captured
in Fig. 1b.
A different approach was used in Askenazi et al. [18]
where the specific purpose was to gain an understanding
of previously undetermined network relationships con-
necting gene expression and secondary metabolism in
the filamentous fungi Aspergillus terreus. In this network
creation study, the researchers needed to compare the
transcriptional and metabolomics read-outs among
A B C
Fig. 1 The number of perturbations and the number of -omics levels determine the possible read-outs. The number of biological states, or perturbations,
that are compared in a multi-omics study define the type of information that can be learned. a Graphical depiction of the relative read-out of a single value
from an individual -omics study (here, a metabolite) in biological states A and B. b Relative read-out from an integrated -omics study comparing two
biological states A and B (using metabolomics (MxP) and transcription (TxP) in this graphic), where each axis is the relative signal of treatment vs. control
for each separate -omics regime. These data can be used to improve understanding of existing networks for the system in these two states; however, it
cannot provide information about the general relationships between the molecules measured in the two -omics readouts. c Relative integrated read-out
from a multi-state experiment, where E1-Ei represent the different states (e.g., perturbations or time points). These integrated data can potentially reveal a
new network capturing the relationships between the metabolites and transcripts of the integrated -omics readouts
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many different states in order to empirically build up the
relationships that comprise the novel network (akin to
Fig. 1c), where in this case the multiple perturbed states
were created by transformation of the fungi using a li-
brary of approximately 400 transcription factors and so-
called global regulator genes. The first step in integra-
tion was once again to acquire a clear picture of the
variation, signal-to-noise, and patterning captured in
each -omics regime individually (see Fig. 2 in [18]). Note
that in this case, the specific data of the study was used
to boot-strap statistical distributions and confidence in-
tervals in the transcript profiling data. To integrate the
two read-outs, in the absence of comparable scales for
the magnitude of change in each -omics, a categorical
statistical relationship, Goodman and Kruskal’s gamma
[19], was chosen as the measure of association between
transcription and metabolism. Applying these categorical
statistics, they were able to discover the biosynthetic
cluster responsible for production of the polyketide Geo-
din, a significant secondary metabolite in cultures of of
A. terreus.
Note that in each case, regardless of the aim to reveal
previously unknown network relationships between the
different -omics vs. the aim of bolstering insight within a
pre-existing network, these studies required incorpor-
ation of the statistical distributions within each -omics
domain individually before the integrated conclusions
could be drawn.
Design challenge 2: non-obvious relationships
exist between -omics regimes within their original
biological context
In the integration of different -omics data types, it is also
extremely helpful to take into account the inherent rela-
tionship between the biological regimes represented by
the respective -omics readouts. The most familiar of such
relationship is the central dogma of molecular biology:
genes to transcripts to protein. However, metabolomics is
a functional readout that is subsequent to the central
dogma framework, and metabolites can loop back into it
at multiple, less familiar points (Fig. 2). For example, they
serve as both substrates and products in enzymatic reac-
tions, they are the monomers from which protein and
RNA are synthesized, they can allosterically regulate the
activity of enzymes or the folding or RNA molecules, and
they can allosterically regulate the activity of transcription
factors and thus indirectly the expression of multiple
genes. Thus, the process of integrating -omics is an effort
to disentangle multiple cycles of functional relationships,
rather than an effort to reveal linear connections. De-
scribed below are just a few cases where less familiar rela-
tionships between levels have been revealed through
integrated -omics studies or else used to enhance the
strength of conclusions from integrated studies.
The relationship between individual enzymes and their
substrates and products can be described by the well-
established equations for enzyme kinetics. Linking these
equations for the enzymes and metabolites of one path-
way into one unified set of differential equations has
been achieved [20, 21]. However, the strongly non-linear
behavior of these equations, particularly when connected
into pathway-level systems, and the challenge of hand-
ling these by numerical computations have greatly lim-
ited the extension of kinetic models to the genome scale.
Despite this limitation, understanding general features of
the relationship between enzymes and metabolites at the
genomic level is highly desirable when considering the
integration of proteomic and metabolomic datasets.
This relationship between metabolite and enzyme
levels has been studied experimentally in Saccharomyces
cerevisiae by combing standardized enzyme kinetics and
statistical analysis with multi-omics integration [22]. In
this network function study, hypotheses were validated
against a comprehensive collection of transcriptional,
proteomic, and metabolomic datasets on S. cerevisiae in
which levels of enzymes were experimentally perturbed.
The resulting data validated previous observations that
metabolite concentrations are on the order of the kM
values [23] and further provided observation of an in-
verse correlation of metabolite and enzyme fold changes
upon alteration in enzyme abundance. Moreover, it was
shown that perturbations to single enzymes trigger only
local alteration in metabolite abundance. The practical
conclusion is that metabolomics data can be used as a
read out for enzyme activity that is indirect yet covers
multiple enzymes simultaneously; the fundamental
Fig. 2 The relationship among the -omics levels beyond the central
dogma of molecular biology. The relationship among the -omics
(blue) is multifold. Enzyme catalysis and then central dogma of
molecular biology are the most prominent relationships (grey).
Additional relationships (green) can become important for the
integration of -omics data depending on the experimental setup
and time-scales analyzed
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biological conclusion is that metabolic networks realize a
trade-off between minimizing the abundance of enzymes
and of metabolite that enables maintenance of flux
homeostasis despite perturbations, without the need for
transcriptional regulation. The correlation of transcripts
(as surrogates for enzyme activity) and metabolites was
subsequently generalized and termed Concentration
Change Coupling Analysis in an independent report from
Zelezniak et al. [24].
The flow of small molecule metabolites into the as-
sembly of macro-molecules such as proteins and poly-
nucleic acids represents a trans-omics relationship that
may become a factor in some experimental designs as
well. The impact of the obvious fact that RNA is synthe-
sized from metabolites was demonstrated for the re-
sponse of S. cerevisiae to a sudden relief of glucose
limitation [25]. The authors observed a disproportionally
fast degradation of transcripts from genes that were
downregulated in response to relief of glucose limitation.
These were demonstrated to result from mRNA degrad-
ation as a nucleotide salvage pathway that served to
stabilize intracellular nucleotide concentrations in the
face of the increased nucleotide triphosphate demand
for glucose catabolism in the overall regulatory response.
Challenge 3: capitalize on time resolution in
-omics data
The sequence of time-dependent responses at different
-omics levels can serve as an extra dimension of data
that can be considered in designing a biological experi-
ment for integrated -omics. In general, external pertur-
bations trigger a sequence of events that contain
information about the connectivity and the directionality
of underlying biological networks (Fig. 3). This add-
itional layer of information is based on the simple logic
that a cause must precede its effect. Time-resolved (dy-
namic) -omics data sets can therefore serve as a basis to
construct new biological networks and to unravel which
network connections are determined for a given systems
response (note the consistency with the need for multi-
state comparisons, as described above). Ideally, samples
for time-resolved studies can be collected at intervals
that match the dynamics of the molecular system. Asses-
sing the metabolomics response to metabolic and post-
translational perturbations typically requires sampling
on a seconds time scale [26, 27]; the inherent dynamics
of the transcriptional regulation network requires sam-
pling over the course of several minutes to hours. A
baseline observation can be obtained simply by initiating
the sequence of sampling in the unperturbed state.
The response to a physiological perturbation such as
the addition of drugs or nutrients to a cell culture trig-
gers an interconnected metabolic and regulatory re-
sponse. Multiple dynamic -omics data sets are required
to capture the full extent of the cellular response. In
addition, their integration allows the study of the cross-
talk between the -omics—both of which were achieved
in a comprehensive study of integrated cellular response
by Buescher and colleagues [28]. The authors observed
the dynamic response to the addition of nutrients by
metabolomics, transcriptomics, and proteomics in Bacil-
lus subtilis. Samples for different -omics analyses were
taken at intervals ranging 20 s to 150 min (two doubling
times for B. subtilis) following nutrient perturbations,
starting from the same homogeneous culture. Parallel
experiments with over 200 strains expressing GFP re-
porters for promoter activity complement the data set.
Post-transcriptional regulation was detected by a dy-
namic model correlating the time courses of promoter
activity with transcript abundance, and transcripts with
protein levels, respectively, where the simple analysis re-
lies on whether the transcript abundance of a gene
matches the activity of its promoter or the abundance of




Fig. 3 Time-resolved data informs pathway directionality. A schematic model for the interpretation of time course data. The observed time
courses of the levels of A, B, and C, which are known to belong to the same linear pathway reveal the order of the three components in the
pathway and the direction of the flux through the pathway. A, B, and C can be metabolites in a metabolic pathway, phosphorylated proteins in a
kinase cascade, or members of any other matter- or signal-transducing pathway. The component D, for which the network connection to the
ABC pathway is unknown, cannot be upstream of A, and it cannot be downstream of C. This information can be valuable in validating hypotheses
on the network connection of D
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course for related elements across -omics levels is the
most frequent situation. However, the authors detected
110 cases of statistically significant mis-matches in time
across the datasets, which indicate that additional regu-
lation events occurred during or after transcription of
the respective genes. In each case, additional experimen-
tation was required to elucidate the specific regulatory
mechanism underlying a specific mismatch.
For example, a surprisingly slow response to the avail-
ability of glucose was observed: the maximum glucose
uptake rate was realized after about one doubling time,
and metabolite time profiles hinted towards a bottleneck
in glucose utilization upstream of phosphoenolpyruvate.
Next, intra- and extra-cellular metabolomics time
courses were integrated into the known metabolic net-
work to estimate time courses of the net reaction rates
of all reactions in the model. The time courses of these
rates were then correlated with the time courses of the
abundances of the proteins that catalyze these reactions.
A strong positive correlation was observed for the en-
zymes of two operons, which are responsible for glucose
uptake and lower glycolysis, respectively; in addition, the
authors demonstrated that continuous induction of ei-
ther operon allows for instantaneous glucose utilization
immediately after addition. Thus, despite more than half
of all B. subtilis genes showing a significant change in
expression in this experiment (when considering the
endpoint alone), including consideration of time-courses
in the integrated -omics study revealed two specific
regulatory events that govern the cellular adaptation at
the physiological level.
In network creation studies, time resolved -omics data
can greatly assist in the creation of the network connect-
ing the measured entities. A classic example of metabol-
ite profiling, though clearly not a modern “omics” study,
provides an excellent tutorial: the pioneering work ac-
complished by Melvin Calvin and coworkers leading to
the discovery of the CO2 fixation pathway, now known
as Calvin-cycle [29]. Starting in the mid 1940s, they sub-
jected cultures of the unicellular green algea Chlorella to
pulses of 14C labeled CO2 and obtained samples at up to
5-s intervals. By 2D thin layer chromatography, they
then resolved the order in which the label arrives in the
intermediates of the downstream metabolic pathway;
and thus, the pathways of CO2 flow into the central car-
bon metabolite pools.
Modern studies frequently start with a list of candidate
networks to identify the one that best fits the measured
time course data. To identify the allosteric regulation
that governs the glycolytic-to-gluconeogenic switch in
Escherichia coli, Link et al. compiled 126 putative allo-
steric interactions between metabolites and enzymes and
subjected cultures to 30-s pulses of 13C labeled sugars
[27]. Within this short time window, protein abundances
can safely be assumed to be constant, and in this con-
text, time-resolved metabolite labeling was sufficient to
identify eight enzymes that are allosterically activated or
inhibited by up to four (from a total of five) different
metabolites to enable the reversal of flux through one of
the major carbon utilization pathways; one newly discov-
ered allosteric interaction in this work was the activation
of FBP-ase by pyruvate.
One recent study, aimed toward identification of a
new network, tracked time courses for abundance of
metabolites and transcripts following three different per-
turbations of nitrogen metabolism [30]. The authors
identified metabolites lying upstream (“influencing”) or
downstream (“influenced by”) of the transcription factor
TORC1 in S. cerevisiae. This was enabled by systematic
integration of time courses of metabolites and tran-
scripts in a dynamic model and included prior know-
ledge of the targets of the TORC1. This work
independently validated previous hypotheses on TORC1
regulation and additionally highlighted AICAR as a key
regulator of amino acid and nucleotide metabolism.
In case the different sets of -omics data are available
on the same time scale (or can be interpolated to a com-
mon time scale), co-clustering by K-means can identify
related biological entities [31]. This was applied in a
study that subjected cultures of E. coli to five different
stress conditions and observed the cellular response by
quantifying transcripts and metabolites multiple time
points before and after the onset of the stress condition.
With this unsupervised clustering approach, the authors
could find the association of metabolites and transcript
fold changes in amino acid synthesis pathways. In
addition, they used canonical-correlation analysis to
identify condition-dependent association between me-
tabolites and enzymes in central carbon metabolism, and
could thereby find metabolic pathways that are of par-
ticular importance in the response to stress.
Conclusions
The integration of -omics data can yield more than the
sum of the individual -omics experiments and poten-
tially provides access to the interactions that can occur
among all classes of molecules in a cell, determining cel-
lular physiology and behavior. Many of the studies gain
insight using two or more -omics data sets captured dur-
ing the same biological process. This integration of mul-
tiple -omics, often captured in parallel during the same
biological process, required the authors to tailor novel
solutions for practical challenges in integrating -omics
data for their particular research questions. For example,
both Zhang et al. [6] and Fendt et al. [22] correlate
metabolomics with expression data (reviewed above).
On the one hand, Zhang et al. do not employ the known
metabolic network as an a priori input but rather use
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correlation analysis to identify genes that are linked to
lipid metabolism. On the other hand, Fendt et al. correl-
ate expression values of enzymes only with the metabo-
lites that are known to participate in the respective
reactions and thus observe how flux homeostasis is pre-
served upon perturbations in enzyme activity.
Both the practical solutions and these fundamental bio-
logical relationships developed using model organisms can
also be applied to clinically relevant fields such as cancer
biology. We expect that future studies employing integra-
tive methods will have groundbreaking impact on our un-
derstanding of cancer on a cellular and on a systemic level
because they bridge the gap between genome-level data
sets and the molecular mechanisms that govern cellular
physiology. Consequently, molecular interactions that are
based on known molecular mechanism, and not only on
association with the same GO term, can then also be stud-
ied on a global scale. Time-resolved data sets are particu-
larly suited for this approach.
The systematic, statistical analysis of data gener-
ated for the same model system is greatly facilitated
by the development of shared experimental material
such as the NCI60 panel of cancer cell lines [32] or
the human tumor panel TCPA [33]. The widespread
access to these biological resources removes the
need to generate all the required -omics data within
a single study. Instead, -omics data sets from the
same panel can be re-analyzed in various combina-
tions and from various perspectives and can build
up on each other going forward. Historically, the
field of cancer research has been particularly effect-
ive in assembling these types of open resources for
the community, and we anticipate that as integrated
-omics studies become more frequent in cancer re-
search, many novel pathways and targets for therapy
will be revealed.
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